On February 28, 2023 Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, reported that Scott Hutton, Chief Executive Officer of Biodesix, will participate in a fireside chat and host in-person 1×1 investor meetings at Cowen’s 43rd Annual Healthcare Conference being held from March 6-8, 2023 (Press release, Biodesix, FEB 28, 2023, View Source [SID1234627916]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen’s 43rd Annual Healthcare Conference
Fireside Chat Date: Tuesday, March 7, 2023
Fireside Chat Time: 1:30 PM ET
Location: Boston Marriott Copley Place

The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of the Company’s website at www.biodesix.com.